| Literature DB >> 34427972 |
Sarah Sharabiany1, Gaby J Strijk1, Robin D Blok1, Colin G Ferrett2, Jaap Stoker3, Christopher Cunningham4, Jarmila D W van der Bilt5, Anna A W van Geloven6, Wilhelmus A Bemelman1, Roel Hompes1, Gijsbert D Musters1, Pieter J Tanis1.
Abstract
AIM: This study aimed to quantify displacement of urogenital organs after abdominoperineal resection (APR), and to explore patient and treatment characteristics associated with displacement.Entities:
Keywords: abdominoperineal resection; quantification of displacement; rectal cancer; urogenital organs
Mesh:
Year: 2021 PMID: 34427972 PMCID: PMC9291959 DOI: 10.1111/codi.15885
Source DB: PubMed Journal: Colorectal Dis ISSN: 1462-8910 Impact factor: 3.917
FIGURE 1Anatomical reference lines used for comparing location of anatomical landmarks between pre‐ and postoperative images in men (left) and women (right). Coordinate system for measuring absolute displacement: y‐axis (blue line) between anterior inferior border of fifth lumbar vertebra (L5) and posterior inferior border of the pubic bone (PB), and x‐axis (red line) from the anterior inferior border of the fifth sacral vertebra (S5) and perpendicular to the y‐axis. Reference line between posterior inferior border of the pubic bone and anterior inferior border of the fifth sacral vertebra (white) for measuring rotation of the anatomical landmarks. Anatomical landmarks for both genders are the internal urethral orifice (IUO) and posterior bladder wall (PBW). Additional landmarks are the distal end of the prostatic urethra (DPU) in men, and the cervix or top of vagina (C) in women
FIGURE 2Flow diagram of patient inclusion
Baseline characteristics
| Male ( | Female ( | ||
|---|---|---|---|
| Age | Years (mean ± SD) | 64 ± 12 | 64 ± 13 |
| BMI | kg/m2 (mean ± SD) | 27 ± 5 | 27 ± 6 |
| Prior pelvic surgery | Total | 29/171 (17) | 35/77 (46) |
| Sacral colpopexy | – | 4/77 (5) | |
| Caesarean section | – | 5/77 (7) | |
| Oophorectomy | – | 6/77 (8) | |
| Hysterectomy | – | 14/77 (18) | |
| Sterilization | 1/171 (1) | 5/77 (7) | |
| TURP or TURBT | 7/171 (4) | – | |
| (Partial) prostatectomy | 5/171 (3) | – | |
| TEM | 4/171 (2) | 5/77 (7) | |
| Low anterior resection | 9/171 (5) | 6/77 (8) | |
| Other | 6/171 (4) | 7/77 (9) | |
| APR indication | Primary rectal cancer | 155/171 (91) | 69/77 (90) |
| Recurrent rectal cancer | 16/171 (9) | 8/77 (10) | |
| Neoadjuvant treatment | None | 22/169 (13) | 8/77 (10) |
| Short‐course radiotherapy | 27/169 (16) | 13/77 (17) | |
| Long‐course radiotherapy | 39/169 (23) | 18/77 (23) | |
| Chemoradiotherapy | 81/169 (48) | 38/77 (49) | |
| APR type | Intersphincteric | 21/168 (13) | 4/77 (5) |
| Conventional | 41/168 (24) | 15/77 (20) | |
| Extralevator | 106/168 (63) | 58/77 (75) | |
| Additional resection | Total | 57/168 (34) | 41/77 (53) |
| Vaginal wall | – | 26/77 (34) | |
| Adnex | – | 9/77 (12) | |
| Uterus | – | 6/77 (8) | |
| Seminal vesicle | 13/168 (8) | – | |
| (Partial) Prostate | 17/168 (10) | – | |
| Partial bladder | 4/168 (2) | 0/77 (0) | |
| Coccyx | 26/168 (16) | 13/77 (17) | |
| Pelvic side wall | 5/168 (3) | 4/77 (5) | |
| Presacral fascia | 1/168 (1) | 1/77 (1) | |
| Omentoplasty | Total | 68/171 (40) | 37/77 (48) |
| Visceral interposition | Total | 1/134 (1) | 6/63 (10) |
| Uterus | – | 6/63 (10) | |
| Caecum | 1/134 (1) | 0/63 (0) | |
| Perineal closure | Primary closure | 89/168 (53) | 38/77 (49) |
| Biological mesh | 47/168 (28) | 22/77 (29) | |
| Resorbable synthetic mesh | 28/168 (17) | 9/77 (12) | |
| Gluteal turnover flap | 2/168 (1) | 2/77 (3) | |
| Muscle flap | 2/168 (1) | 6/77 (8) |
Data are presented as absolute numbers (proportions), unless otherwise stated.
Abbreviations: APR, abdominoperineal resection; BMI, body mass index; SD, standard deviation; TEM, transanal endoscopic microsurgery; TURBT, transurethral resection of bladder tumour; TURP, transurethral resection of the prostate.
Measured urogenital displacements in male and female patients who underwent abdominoperineal resection on sagittal pelvic imaging
| Absolute displacement of anatomical landmarks (mm) | Male ( | Female ( | ||||
|---|---|---|---|---|---|---|
|
|
Median (IQR) |
Range (min–max) |
|
Median (IQR) |
Range (min–max) | |
| Direction of displacement | ||||||
| Internal urethral orifice ( | ||||||
| Any | 170 | 25 (17–33) | 0–65 | 73 | 17 (10–31) | 2–50 |
| Dorsal‐caudal | 122 | 27 (19–34) | 4–65 | 47 | 20 (13–31) | 2–50 |
| Dorsal‐cranial | 32 | 23 (16–32) | 0–42 | 19 | 18 (10–30) | 4–46 |
| Ventral‐cranial | 4 | 6 (6–22) | 5–27 | 2 | 7 | 4–9 |
| Ventral‐caudal | 12 | 9 (6–19) | 3–27 | 5 | 7 (6–10) | 6–11 |
| Posterior bladder wall ( | ||||||
| Any | 171 | 32 (25–44) | 1–83 | 77 | 36 (24–47) | 3–75 |
| Dorsal‐caudal | 116 | 32 (26–43) | 3–83 | 39 | 41 (27–48) | 4–75 |
| Dorsal‐cranial | 43 | 36 (21–46) | 2–77 | 32 | 36 (24–47) | 3–67 |
| Ventral‐cranial | 3 | 35 | 10–44 | 1 | 11 | – |
| Ventral‐caudal | 9 | 18 (14–31) | 1–39 | 5 | 20 (14–26) | 8–28 |
| Distal end of prostatic urethra ( | ||||||
| Any | 163 | 12 (9–17) | 1–76 | – | – | – |
| Dorsal‐caudal | 84 | 14 (10–19) | 1–76 | – | – | – |
| Dorsal‐cranial | 31 | 11 (6–15) | 2–28 | – | – | – |
| Ventral‐cranial | 10 | 8 (2–13) | 2–25 | – | – | – |
| Ventral‐caudal | 38 | 12 (8–18) | 1–28 | – | – | – |
| Cervix/top of the vagina ( | ||||||
| Any | – | – | – | 58 | 40 (27–46) | 8–77 |
| Dorsal‐caudal | – | – | – | 36 | 40 (27–46) | 11–77 |
| Dorsal‐cranial | – | – | – | 19 | 39 (23–50) | 9–70 |
| Ventral‐cranial | – | – | – | 0 | – | – |
| Ventral‐caudal | – | – | – | 3 | 32 | 8–54 |
| Degrees of rotation | ||||||
| Internal urethral orifice ( | ||||||
| Caudal | 160 | 32 (23–41) | 2–85 | 65 | 33 (14–47) | 0–83 |
| Cranial | 10 | 9 (4–13) | 0–25 | 8 | 8 (3–12) | 0–25 |
| Posterior bladder wall ( | ||||||
| Caudal | 164 | 22 (15–30) | 0–59 | 72 | 33 (15–42) | 0–64 |
| Cranial | 7 | 8 (2–10) | 1–26 | 5 | 6 (4–8) | 4–10 |
| Distal end of prostatic urethra ( | ||||||
| Caudal | 134 | 25 (13–38) | 0–86 | – | – | – |
| Cranial | 29 | 11 (5–27) | 0–102 | – | – | – |
| Cervix/top of the vagina ( | ||||||
| Caudal | – | – | – | 56 | 29 (16–34) | 2–75 |
| Cranial | – | – | – | 2 | 6 | 5–6 |
FIGURE 3Boxplots showing the absolute displacement of the internal urethral orifice in millimetres for different subgroups of patients: with or without omentoplasty (OP), hysterectomy or not in women, depending on pelvic floor closure with a biological mesh or not, depending on filling of the presacral space with omentum, small bowel (SB) or a combination of omentum or tissue flap and SB, and depending on whether or not they received neoadjuvant radiotherapy